GeoVax Labs, Inc.Find Ratings Reports
GEOVAX LABS INC's gross profit margin for the second quarter of its fiscal year 2021 has significantly decreased when compared to the same period a year ago. Sales and net income fell significantly, underperforming compared to the average company in its subsector. GEOVAX LABS INC is extremely liquid. Currently, the Quick Ratio is 54.43 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.
At the same time, stockholders' equity ("net worth") has greatly increased by 1,151.78% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY21||Q2 FY20|
|Net Sales ($mil)||0.08||0.44|
|Net Income ($mil)||-1.31||-0.46|
|Balance Sheet||Q2 FY21||Q2 FY20|
|Cash & Equiv. ($mil)||19.54||0.71|
|Total Assets ($mil)||19.82||0.96|
|Total Debt ($mil)||0.0||0.64|
|Profitability||Q2 FY21||Q2 FY20|
|Gross Profit Margin||-1842.5||-101.59|
|Return on Assets||-24.14||-215.65|
|Return on Equity||-24.59||0.0|
|Debt||Q2 FY21||Q2 FY20|
|Share Data||Q2 FY21||Q2 FY20|
|Shares outstanding (mil)||6.33||0.69|
|Div / share||0.0||0.0|
|Book value / share||3.07||-2.67|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||2841473.0||2397099.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.31 indicates a significant discount versus the S&P 500 average of 4.74 and a significant discount versus the subsector average of 10.99. The price-to-sales ratio is well above the S&P 500 average, but well below the subsector average. After reviewing these and other key valuation criteria, GEOVAX LABS INC proves to trade at a discount to investment alternatives.
|GOVX NM||Peers 35.44||GOVX 24.24||Peers 21.78|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
GOVX's P/E is negative making this valuation measure meaningless.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
GOVX is trading at a premium to its peers.
|GOVX NM||Peers 19.02||GOVX NA||Peers 1.05|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
GOVX's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|GOVX 1.31||Peers 10.99||GOVX 99.89||Peers 55.21|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
GOVX is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
GOVX is expected to have an earnings growth rate that significantly exceeds its peers.
|GOVX 29.65||Peers 78.20||GOVX -51.28||Peers 500.96|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
GOVX is trading at a significant discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
GOVX significantly trails its peers on the basis of sales growth.